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Notwithstanding the examples of Lind, Jenner and self-experi-
mentation, which were discussed in the previous issue,[1] examples 
of experimental research where people with vulnerabilities have 
been harmed have surfaced since medieval times. While not typical 
of experiments of that era, in the thirteenth century, Frederick II of 
Germany is said to have experimented with neonates so he could 
obtain knowledge about the development of language in humans.[2] 
Avicenna, an Arabian physician and philosopher, tested interventions 
directly on people because he felt that testing these on animals would 
not have any relevance for their use on humans.[2] 
Briggle and Mitcham[3] claim that in the main, the first studies 
of experimentations on humans took place on slaves and the poor, 
and that this coincided with the development of the new science of 
anthropology that Europeans used to study non-European peoples.[3] 
Generally speaking, human experimentation was initially undertaken 
on those who were considered to be uncivilised and often less than 
human, with diminished or no moral status. Even colonial and 
imperial rule was often justified by anthropological research that 
described the native peoples of Africa, the Americas and Asia as being 
of inferior intelligence and ability, and hence in need of paternalistic 
rule by European powers or immigrants. Their anthropological 
findings were based on the category of race.[3]
In this article, the Nuremberg Trials and their implications 
are briefly discussed. The emergence of international norms and 
standards for protection of participants in research is considered, 
together with South Africa (SA)’s response to the global scandals and 
tragedies in health research.
The proceedings of the Nuremberg Trials 
Among the greatest tragedies in human research experimentation, the 
heinous studies conducted during World War II by Nazi doctors on 
‘racially inferior’ Jews and other ‘deficient’ groups,[4-8] and by Japanese 
doctors on people, in the main Chinese, that they determined to be 
less than human[3,9,10] take centre stage as the most notorious.
In the aftermath of World War II, the horrors of experimentations 
on concentration camp inmates were publicised during the 
Nuremberg Trials in Germany, which lasted from December 1946 
to August 1947.[3,5,7,11] The trial specific to the medical atrocities is 
the case of the United States of America v Karl Brandt et al. – also 
referred to as the Nuremberg Doctors’ Trial.[12] Evidence given at 
the trial underscored the robust and relentless exploitation and 
wrongs prevalent in medical studies at that time. The vulnerable 
were considered to be subhuman, of low intelligence, of no moral 
status and lacking human dignity. The Nuremberg Doctors’ Trial 
raised insightful issues on how and why doctors who were trained 
in the Hippocratic tradition were able to commit such egregious and 
heinous medical crimes. As medicine was supposed to be one of the 
‘world’s most advanced scientific cultures’,[11] questions on whether 
these doctors actually understood that they were committing crimes 
were raised. The defendants’ lawyers during the Nuremberg Doctors’ 
Trial, using a utilitarian approach, highlighted that the Allies had also 
engaged in medical experiments in servicing the war effort,[5,11] that 
the type of medical experimentation performed in the concentration 
camps during the war was commonplace even before the war[11] 
and that there were no legal restrictions on such experiments.[6] As 
the prosecution’s attempts at demonstrating that there were clear 
international rules governing medical experimentation wavered, the 
judges attempted to create their own set of rules, and two medical 
advisors to the judges, Drs Andrew Ivy and Leo Alexander, were 
tasked to do this.[4-6] They drafted a ten-point memorandum entitled 
Permissible Medical Experimentation,[7] which then became known as 
the Nuremberg Code, the aim of which was to obtain a way forward 
on one of human experimentation’s most fundamental conflicts: that 
of balancing the need for advancing medical science for the benefit 
of society with the rights of individuals to ‘personal inviolability, 
autonomy and self-determination’.[11]
The trial, however, was based on international law as outlined in 
the London Agreement on the Punishment of the Major War Criminals 
of the European Axis (London Charter) in 1945.[12,13] Although 
international law had previously not codified specific war crimes, 
the crimes specified in the London Charter included those contained 
in the Hague Regulation of Warfare (1907),[14] which Germany 
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had signed.[12] Germany had also signed the Kellogg-Briand Pact 
of 1928,[15] which condemned aggressive wars, and the Geneva 
Convention[16] in 1929, which specified in its rules how prisoners of 
war should be protected.[12] Therefore, both the judgment and the 
Code were de jure international in character. The Nuremberg Code is 
hence undoubtedly the first international medical ethics code.  
It is interesting to note that besides Germany being signatory to 
international instruments for protection of prisoners of war, by the 
end of the 19th century it had started to develop some of the world’s 
most stringent and clearly defined medical ethics regulations,[2] and 
in March 1931, the Reich Health Council (Reichsgesundheitstrat) 
issued the Regulations Concerning New Therapy and Human 
Experimentation.[17] The far-reaching directives in these regulations 
were ‘among the most comprehensive research rules by any standard 
at the time’.[2] Some aspects that involved contentious issues such as 
voluntary informed consent, therapeutic research, non-therapeutic 
research and benefits were much more structured and detailed 
compared with the principles in the Nuremberg Code. It was stressed 
that the rights and dignity of subjects had to be protected at all 
times, and on the issue of non-therapeutic research it underscored 
the prohibition of experimentation in all cases where consent had 
not been given. Unfortunately, despite the strong protectionism 
in the regulations, respect for moral status, upholding dignity 
and according special protections for subjects enrolled in research 
– fundamental values highlighted in the Reich Health Council’s 
regulations – were ignored.      
The international medical community had no option but to reflect 
on its conduct in the aftermath of World War II and the Nuremberg 
Doctors’ Trial. There were now great uncertainties regarding the role 
that the medical profession had to play in a post-war society. This 
was of huge concern to national medical associations as well.[18] 
The reputation of the medical profession had been undermined, 
professionalism questioned and the doctor-patient relationship 
damaged as a result of the Nazi medical experiments. Doctors all 
over the world were anxious that the profession as a whole could 
be affected negatively by the sweeping condemnation of the Nazi 
physicians. Therefore, it is not surprising that the revelations at the 
Trial were also a major factor leading to the foundation of the World 
Medical Association (WMA).[19]
The role of the WMA
At the first meeting to discuss an international association of doctors 
and national medical societies held in London in 1946, there were 
32 national medical organisations present. The objective of such an 
international association would be to promote international medical 
relations, and the advancement of medicine and its social and cultural 
aspects. The first meeting of the newly formed WMA in 1947 was 
held 1 month after judgments had been delivered in the Nuremberg 
Doctors’ Trial.[20] The Declaration of Geneva,[21] a statement on 
the physician’s dedication to the medical profession, was among 
the first acts of the WMA and was endorsed at the 1948 General 
Assembly. The importance of this declaration is that when adopted, 
considerations of nationality, race, party politics and social class 
would not interfere with the physician’s responsibility for the patient’s 
welfare. This applied to both situations of clinical care and research. 
Already in its very first declaration, the WMA had started the process 
of protectionism for those patients involved in research.
The Declaration of Helsinki (DoH) of 1964 was among the first 
international guidelines for human experimentation and it ‘reflected 
the longstanding interest of the WMA in issues of medical ethics and 
the enduring shadow of the Nazi medical war crimes.’[20] The journey 
of the first DoH was long and turbulent. It involved more than a 
decade of active discussion and debate among the WMA members 
before the final document, which was also strongly influenced by the 
principles of deontology and virtue ethics, could be presented to the 
WMA’s General Assembly for adoption in Helsinki in 1964.[20] The 
DoH has been hailed as one of the most successful efforts in rescuing 
medical research from the darkness of the tragedies resulting from 
the heinous atrocities in the name of medical research in Nazi 
Germany.[20] It has undergone several revisions, with the latest being 
in October 2013. 
Protectionism in SA[22]
Henry Knowles Beecher, [23]  a professor in research into anaesthesia, 
published a landmark article in the New England Journal of Medicine 
in 1966, entitled ‘Ethics and clinical research’. This article was 
the catalyst for the establishment of protectionism for research 
participants in SA. Beecher detailed 22 cases of research conducted 
by leading researchers at leading research centres that he claimed 
violated the basic standards of ethical research. These studies had 
been published in highly acclaimed and reputable reviewed journals. 
He had submitted 50 cases in his original list but the number had to 
be reduced due to the space constraints of the journal.[6]
The history of protectionism from a regulatory perspective in 
SA is quite meagre, and only emerged over the past 2 decades. This 
is understandable, as prior to 1994, citizens in the country were 
oppressed and subjected to the repressive apartheid regime in which 
people who were not white were considered to be subhuman, lacking 
human dignity and of decreased or no moral status, similar to the 
European anthropological viewpoint described above. However, the 
apartheid regime and philosophy were not successful in removing 
moral agency from the virtuous physician-researcher in the country, 
and in the late sixties, after Beecher’s seminal paper was published,[23] 
steps were set in motion at the level of individual institutions 
where research was conducted to introduce protections for all, 
and in particular the vulnerable, who were involved in research. 
Cleaton-Jones[24] states that the Beecher paper was considered such 
a milestone in research ethics that 4 months after its publication, at 
the suggestion of Prof. John Hansen of the Department of Paediatrics 
at the then Baragwanath Hospital, which was situated in a racially 
demarcated township, Soweto, the University of the Witwatersrand 
formed the Committee for Research on Human Subjects (Medical). 
Hence, this could be described as the birth of protectionism for 
research participants in SA. The committee was the first research 
ethics committee (REC) in the country, and probably one of the 
first in the world. The committee underwent a name change in 2003 
to the Human Research Ethics Committee (Medical)[24] and is still 
functional today, and is probably one of the leading RECs in the 
country. From the mid-1970s, other institutions followed suit, and 
currently there are over 45 RECs registered with the National Health 
Research Ethics Council in the country.[25]  
In the beginning, guidelines for the protection of participants in 
research were lacking in the country. However, in 1978, Prof. de V 
Lochner, then vice-president of the SA Medical Research Council 
(SAMRC), visited the World Health Organization in Geneva, and 
upon his return, set to work producing a set of guidelines for the 
SAMRC. In 1979, the first set of guidelines, entitled Guidelines on 
Ethics for Medical Research, was produced by the SAMRC. These 
guidelines have undergone several revisions since.[24]
The National Department of Health in 2000 produced Guidelines for 
Good Clinical Practice in Research.[24] This was updated in 2006.[26] The 
promulgation of the National Health Act (NHA) No. 61 of 2003,[27]  in 
2004, resulted in strong protectionism for research participants in the 
country. Chapter 9 of the NHA focuses on health research and health 
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research ethics. As a result of the stipulations of chapter 9, Ethics in 
Health Research: Principles, Structures and Processes[28] was launched in 
2004. It was a response to the NHA and, while written as guidelines, 
had the authority of rules. It has undergone amendment, with the 
second edition being issued in 2015.[29] 
Conclusion[22]
Exploitation in health research of the vulnerable who were considered 
to be subhuman, lacking in intelligence, moral status and human 
dignity goes back several centuries. Germany was both signatory to 
international instruments for protections of prisoners of war and also 
had a stringent set of guidelines for protection of participants in medical 
research. Despite this, evidence given during the Nuremberg Trials 
highlighted the robust and relentless abuse, mistreatment and wrongs 
prevalent in medical studies at that time. The WMA’s DoH provides 
international norms and standards for protections. In SA, individual 
institutions responded to the global position by setting up RECs to 
provide ethical oversight in health research, which have existed since 
the 1960s. This became a statutory requirement in the early 2000s. In 
the next issue of the SAMJ, I will describe the development of the ethico-
regulatory protections in health research in the country.  
1. Dhai A. Health research and safeguards: The South African journey. S Afr Med J 2017;107(5):379-380. 
https://doi.org/10.7196/SAMJ.2017.v107i5.12345
2. Von Engelhardt D. The historical and philosophical background of ethics in clinical research. In: 
Schmidt U, Frewer A, eds. History and Theory of Human Experimentation. Germany: Franz Steiner 
Verlag, 2007:55-70.
3. Briggle A, Mitcham C. Research ethics 11: Science involving humans. In: Briggle A, Mitcham C, eds. 
Ethics and Science. Cambridge: Cambridge University Press, 2012:125-155.
4. Emanuel EJ, Crouch RA, Arras JD, Moreno JD, Grady C. Scandals and tragedies of research with 
human participants. In: Emanuel EJ, Crouch RA, Arras JD, Moreno JD, Grady C, eds. Ethical and 
Regulatory Aspects of Clinical Research. Baltimore: John Hopkins University Press, 2003:1-5. 
5. Moreno JD. Protectionism in Research Involving Human Subjects (Research Involving Human 
Subjects V2). Online Ethics Centre for Engineering, 2006. http://www.onlineethics.org/Topics/
ResResearch/ResResources/nbachindex/hmoreno.aspx (accessed 20 July 2012).   
6. Emanuel EJ, Crouch RA, Arras JD, Moreno JD, Grady C. Preface xv-xviii. In: Emanuel EJ, Crouch RA, 
Arras JD, Moreno JD, Grady C, eds. Ethical and Regulatory Aspects of Clinical Research. Baltimore: 
John Hopkins University Press, 2003.
7. Levine C, Faden R, Grady C, Hammerschmidt D, Eckenwiler L, Sugarman J. The limitations of 
vulnerability as a protection for human research participants. Am J Bio 2004;4(3):44-49. http://doi.
org/10.1080/15265160490497083
8. Iltis AS. Introduction: Vulnerability in biomedical research. J Law Med Ethics 2009;37(1): 6-11. http://
doi.org/10.1111/j.1748-720X.2009.00345.x
9. McDermott W. Opening Comments on the Changing Mores of Biomedical Research. Ann Intern Med 
1967;67(7):39-42.
10. Wikipedia, the free Encyclopaedia. Unit 731. https://en.wikipedia.org/wiki/Unit_731 (accessed 27 
June 2013).
11. Bärninghausen T. Communicating ‘Tainted science’: The Japanese biological warfare experiments on 
human subjects in China. In: Schmidt U, Frewer A, eds. Germany: Franz Steiner Verlag, 2007:117-142. 
12. Schmidt U. The Nuremberg Doctors’ Trial and the Nuremberg Code. In: Schmidt U, Frewer A, eds. 
History and Theory of Human Experimentation. Germany: Franz Steiner Verlag, 2007:71-116.
13. Taylor T. Opening statement of the prosecution, December 9, 1946. In: Annas GJ, Grodin MA, eds. The 
Nazi Doctors and the Nuremberg Code. New York: Oxford University Press, 1992:67-93.
14. International Committee of the Red Cross. Convention (IV) Respecting the laws and customs of war 
on land and its annex: Regulations respecting the laws and customs of war on land. The Hague, 18 
October 1907. http://www.icrc.org/applic/ihl/ihl.nsf/52d68d14de6160e0c12563da005fdb1b/1d172642
5f6955aec125641e0038bfd6 (accessed 16 July 2014).
15. Office of the Historian. The Kellogg-Briand Pact of 1928. https://history.state.gov/milestones/1921-1936/
kellogg (accessed 16 July 2014). 
16. International Committee of the Red Cross. Convention relative to the treatment of prisoners of war. 
Geneva, 1929. http://www.icrc.org/ihl/INTRO/305 (accessed 16 July 2014). 
17. Sass HM. Reichsgesundheitstrat 1931: Pre-Nuremberg German regulations concerning new therapy 
and human experimentation. J Med Philos 1983;8(2):99-111.
18. Weindling PJ. Human guinea pigs and experimental ethics: The BMJ’s foreign correspondent at the 
Nuremberg Medical Trial. BMJ 1996;313:1467-1470. https://doi.org/10.1136/bmj.313.7070.1467
19. Faden RR, Lederer SE, Moreno JD. US medical researchers, the Nuremberg Doctors’ Trial, and the 
Nuremberg Code: A review of findings of the Advisory Committee on Human Radiation Experiments. 
JAMA 1996;276(20):1667-1671.
20. Lederer SE. Research without borders: The origins of the Declaration of Helsinki. In: Schmidt U, Frewer 
A, eds. History and Theory of Human Experimentation. Germany: Franz Steiner Verlag, 2007:145-164. 
21. World Medical Assembly. Declaration of Geneva. http://www.wma.net/en/30publications/10policies/
g1/ (accessed 17 July 2014). 
22. Dhai A. A study of vulnerability in health research. PhD thesis. Johannesburg: University of the 
Witwatersrand, 2015. 
23. Beecher HK. Ethics and clinical research. N Engl J Med 1966;274(24); 1354-1360. https://doi.
org/10.1056/NEJM196606162742405
24. Cleaton-Jones PC. Research ethics in South Africa: Putting the Mpumalanga case into context. In: 
Lavery J, Grady C, Wahl ER, Emanuel EJ, eds. Ethical Issues in International Biomedical Research. 
Oxford: Oxford University Press, 2007:240-245.
25. The National Health Research Ethics Council. List of Registered RECs 2013. www.nhrec.org.za/index.
php/extras?download=7:list-of-recs-registered (accessed 24 May 2017).
26. South African National Department of Health. The South African Good Clinical Practice Guidelines 
2006. http://www.nhrec.org.za/wp-content/uploads/2008/09/gcp.pdf (accessed 28 June 2013).
27. South Africa. National Health Act No. 61 of 2003. 
28. South African National Department of Health. Ethics in Health Research: Principles, Structures and 
Processes 2004. http://www.nhrec.org.za/wp-content/uploads/2008/09/ethics.pdf (accessed 28 June 2013).
29. South African National Department of Health. Ethics in Health Research. Principles, Processes and 
Structures 2015. http://www.nhrec.org.za/docs/Documents/EthicsHealthResearchFinalAused.pdf 
(accessed 20 December 2015).
Accepted 17 March 2017.
